IRDiRC is pleased to announce the appointment of 3 new members to the Therapies Scientific Committee (TSC):
- Cynthia Rothblum-Oviatt, Science Policy Analyst, CDER/FDA (USA)
- Nancy Casanova, Associate Professor, University of Florida (USA)
- Sara Elgott, Managing Director, OpalMedica (UK)
The Therapies Scientific Committee brings together international experts committed to advancing therapeutic development in rare diseases. By fostering collaboration across sectors, the committee contributes to accelerating research, supporting innovation, and ultimately improving patient outcomes.
We look forward to working closely with these distinguished experts to drive progress in rare disease therapies.
More information about TSC: https://irdirc.org/tsc/